BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 576533)

  • 1. Serum cortisol appearance-disappearance in adrenal insufficiency after oral cortisone acetate.
    Barbato AL; Landau RL
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):600-4. PubMed ID: 576533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: assessment with ACTH profiles.
    Ekman B; Blomgren J; Andersson PO; Carlsson M; Arnqvist HJ
    Horm Metab Res; 2010 Dec; 42(13):961-6. PubMed ID: 20925018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACTH suppression after oral administration of cortisone in Addisonian and adrenalectomized patients.
    Aanderud S; Myking OL; Bassøe HH
    Acta Endocrinol (Copenh); 1982 Aug; 100(4):588-94. PubMed ID: 6289586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortisol and cortisone acetate in parenteral glucocorticoid therapy?
    Kehlet H; Madsen SN; Binder C
    Acta Med Scand; 1974 May; 195(5):421-3. PubMed ID: 4830060
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma cortisol concentrations after oral substitution of cortisone in the fasting and non-fasting state.
    Aanderud S; Myking OL
    Acta Med Scand; 1981; 210(3):157-61. PubMed ID: 7293833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
    Løvås K; Thorsen TE; Husebye ES
    J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on cortisol substitution therapy in patients with adrenal insufficiency.
    Nickelsen T; Schulz F; Demisch K
    Exp Clin Endocrinol; 1983 Jul; 82(1):35-41. PubMed ID: 6311594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid replacement therapy: are patients over treated and does it matter?
    Peacey SR; Guo CY; Robinson AM; Price A; Giles MA; Eastell R; Weetman AP
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution.
    Blomgren J; Ekman B; Andersson PO; Arnqvist HJ
    Scand J Clin Lab Invest; 2004 Apr; 64(2):132-9. PubMed ID: 15115251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary adrenal insufficiency/Addison disease].
    Kolyvanos Naumann U; Nigg C; Käser L; Vetter W
    Praxis (Bern 1994); 2008 Jan; 97(1):4-10; quiz 11-2. PubMed ID: 18260590
    [No Abstract]   [Full Text] [Related]  

  • 11. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
    Charmandari E; Calis KA; Keil MF; Mohassel MR; Remaley A; Merke DP
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease.
    Methlie P; Husebye EE; Hustad S; Lien EA; Løvås K
    Eur J Endocrinol; 2011 Nov; 165(5):761-9. PubMed ID: 21896619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sebum excretion and melanocyte-stimulating hormone in hypoadrenalism.
    Goolamali SK; Plummer N; Burton JL; Shuster S; Thody AJ
    J Invest Dermatol; 1974 Sep; 63(3):253-5. PubMed ID: 4854211
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailability.
    Heazelwood VJ; Galligan JP; Cannell GR; Bochner F; Mortimer RH
    Br J Clin Pharmacol; 1984 Jan; 17(1):55-9. PubMed ID: 6691888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cortisol metabolism in hypertensive patients during the crisis period].
    Shelygina NM; Zaretskiĭ MM; Panichkina VI
    Kardiologiia; 1976 Nov; 16(11):136-9. PubMed ID: 1011454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of absorption of cortisone acetate and hydrocortisone hemisuccinate.
    Fariss BL; Hane S; Shinsako J; Forsham PH
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1137-40. PubMed ID: 233690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency.
    Giustina A; Bresciani E; Bossoni S; Chiesa L; Misitano V; Wehrenberg WB; Veldhuis JD
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1266-72. PubMed ID: 7962318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.
    Alonso N; Granada ML; Lucas A; Salinas I; Reverter J; Oriol A; Sanmarti A
    J Endocrinol Invest; 2004 May; 27(5):449-54. PubMed ID: 15279078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation.
    Kehlet H; Binder C; Blichert-Toft M
    Clin Endocrinol (Oxf); 1976 Jan; 5(1):37-41. PubMed ID: 1248157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.